211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage
Authors:
- A.S. MichalowskiAMA.S. Michalowski
- F. RöschFRF. Rösch
- 1 October 1996
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 32 (11) , 1986-1994
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- [211At]Methylene blue for targeted radiotherapy of human melanoma xenografts: Dose fractionation in the treatment of cutaneous tumoursEuropean Journal of Cancer, 1996
- Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validationBritish Journal of Cancer, 1995
- Toxicity of Astatine-211 in the MouseHuman Toxicology, 1988
- The in Vitro Radiobiology of Astatine-211 DecayRadiation Research, 1986
- Optimization of bombardment conditions of the209Bi/α, 2n/ cyclotron production of211AtJournal of Radioanalytical and Nuclear Chemistry, 1985
- The radiation response of V79 and human tumour multicellular spheroids – cell survival and growth delay studiesBritish Journal of Cancer, 1984
- A lung colony clonogenic cell assay for human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapyBritish Journal of Surgery, 1979
- Studies on the mechanism of drug-binding to melaninBiochemical Pharmacology, 1979
- Electron-donor-acceptor complex formation by compounds of biological interest II. The association constants of various 1,4-dinitrobenzene-phenothiazine drug complexesBiochimica et Biophysica Acta (BBA) - Biophysics including Photosynthesis, 1966
- Electron-donor-acceptor complex formation by compounds of biological interest I. Optical absorption spectra of mixtures of phenothiazines and related compounds with electron acceptorsBiochimica et Biophysica Acta (BBA) - Biophysics including Photosynthesis, 1966